AAV5-RPGR ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
90網膜色素変性症2

90. 網膜色素変性症


臨床試験数 : 147 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04671433
(ClinicalTrials.gov)
March 16, 20215/11/2020Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GenePhase 3 Randomized, Controlled Study of AAV5-RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GeneX-Linked Retinitis PigmentosaBiological: Genetic: AAV5-RPGRMeiraGTx UK II LtdJanssen Research & Development, LLCRecruiting3 YearsN/AAll96Phase 3United States;Denmark;France;Israel;Netherlands;Spain;Switzerland;United Kingdom
2NCT04794101
(ClinicalTrials.gov)
March 16, 202115/12/2020Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GeneFollow-up Phase 3 Randomized, Controlled Study of AAV5-RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GeneX-Linked Retinitis PigmentosaBiological: Genetic: AAV5-RPGR 4e11;Biological: Genetic: AAV5-RPGR 2e11MeiraGTx UK II LtdJanssen Research & Development, LLCRecruiting3 YearsN/AAll96Phase 3United States;Denmark;France;Israel;Netherlands;Spain;Switzerland;United Kingdom